TickerKhojEVONILE · Pharmaceuticals
Evonile Pharma Limited
- Company snapshot
- 2026-11-05
- Latest available quarter
- Not suppliedReporting basis not supplied
- Ownership quarter
- Not supplied
COMPANY COMPARISON · NSE
EVONILE vs SMSPHARMA
Compare business size, valuation, growth and ownership. Higher or lower does not automatically mean better.
SMSPHARMA · Pharmaceuticals
SMS Pharmaceuticals Limited
- Company snapshot
- 2026-11-05
- Latest available quarter
- 2026-09-30Consolidated
- Ownership quarter
- 2026-09-30
Side by side
Choose a metric group. Tap a metric’s explanation button for context.
19 metrics shown
| Metric | EVONILE | SMSPHARMA |
|---|---|---|
| Price | ₹1,716.5 | ₹516.7 |
| Market cap | ₹4,288 cr | ₹4,930 cr |
| P/E | — | 45.9 |
| P/B | 5.5 | — |
| ROE | 11.6% | 14.3% |
| ROCE | 11.8% | 13.9% |
| Debt / equity | 0 | 0.46 |
| Operating margin | 12.1% | 14.8% |
| Dividend yield | 1.44% | 0.08% |
| Sales growth, 3 years (yearly) | -2.2% | 19.3% |
| Profit growth, 3 years (yearly) | -3.4% | — |
| 1-year return | 0.4% | 83.9% |
| Revenue, last 12 months | ₹336 cr | ₹898 cr |
| Net profit, last 12 months | ₹-4 cr | ₹102 cr |
| Latest available quarter | — | Sept 2026 |
| Quarter net profit | — | ₹40 cr |
| Quarter profit vs a year earlier | — | +57.4% |
| Promoter holding | — | 68.07% |
| Health check | Weak (2/10) | Strong (7.1/10) |